American Thinker
It has been known, ever since 1984, that zinc is an effective virus fighter. That year a research study discovered that taking zinc gluconate lozenges early in the course of a common cold could shorten it. After a series of apparently conflicting research studies, a 2012 review of the literature concluded that taking zinc early reduces the duration of a common cold by an average of 1.65 days. Since colds are mild virus infections, it is clear that zinc has anti-virus properties.
...On April 7, two Belgian researchers, Amir Noeparast and Gil Verschelden, published a research paper in which they discussed the research results about the relationship between zinc deficiency and COVID-19. The evidence that they marshal is impressive:
1. Zinc deficiency is prevalent. "Up to a fifth of the global population is estimated to suffer from different degrees of Zinc deficiency. In the western world, Zinc deficiency is more prevalent among the geriatric population, and vegans/vegetarians as well as among people with certain underlying conditions. Notably, the early reports show that the elderly SARS-CoV-2 patients are among those with a higher fatality rate."
2. Women’s bodies make better use of zinc. "It is reported that among the geriatric female population, a gene polymorphism that leads to an increased immune response-mediated release of Zinc is associated with decreased IL-6 level" and thus reduced incidence of fatal Cytokyne Storms.
3. ARDS is more common in people with zinc deficiencies. "Zinc deficiency is associated with an increased risk of acute respiratory distress syndrome (ARDS) in humans."
😜😜😢😂😃😎 |